06 March 2020
Visiongain has launched a new pharma report Gene Therapy R&D and Revenue Forecasts 2020-2030: Retroviruses, Lentiviruses, Adenoviruses, Adeno Associated Virus, Herpes Simplex Virus, Poxvirus, Vaccinia Virus, Naked/Plasmid Vectors, Gene Gun, Electroporation, Lipofection, Cancer, Rare Diseases, Cardiovascular Disorders, Ophthalmologic Conditions, Infectious Disease, Neurological Disorders, Diabetes Mellitus.
The gene therapy market is in early stages of its development, this new Visiongain report analyses the emerging gene therapy market, a field holding great technological and commercial potential. Gene therapy is no longer a treatment solely for rare diseases but has expanded its targets and can now be applied to cancer, cardiovascular diseases, diabetes and more. We have already seen gene therapies launched in recent years and are likely to see upcoming launches due to rapid advancement and the number of clinical trials in this field. Gene therapy has seen many advances in recent years, particularly with vector technology, with AAV and lentiviral vectors showing much potential.
The lead analyst of the report commented "The growth of the overall gene therapy market will be primarily driven by growth in the cardiovascular and rare diseases sector. Clinical trials so far have demonstrated favourable results in a broad range of indications with treatments predicted to launch in the next few years for the cardiovascular disease, rare disease, and cancer submarkets. The market still faces substantial challenges related to ethics, pricing and scalability. Companies looking to market their products optimally should also be developing companion diagnostics for predictive biomarker testing, to market alongside their gene therapies. These companies will also need to agree on creating reimbursements models that will convince health care providers to invest in these novel therapies."
Leading companies featured in the report include UniQure, Biogen, Bluebird Bio, Spark Therapeutics, Applied Genetics Technologies Corporation, Oxford Biomedica, GenSight Biologics and other leading companies currently developing gene therapies. Leading Big Pharma Companies mentioned in this report include Pfizer, Novartis & GSK.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
18 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.
12 January 2021
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
11 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.